Higher beta-blocker doses were associated with improved outcomes in chronic heart failure patients, regardless of atrial fibrillation status.
Do higher beta-blocker doses improve outcomes in patients with chronic heart failure with and without atrial fibrillation?
Real-world data supports the up-titration of beta-blockers to higher doses in chronic heart failure patients, including those with coexisting atrial fibrillation.
Absolute Event Rate: 0% vs 0%
Higher BB doses were associated with improved outcomes in patients with chronic HF, regardless of AF status. These real-world data support up-titration of BBs as a key component in optimized guideline-directed therapy, even in patients with coexisting AF.
Lábr et al. (Sun,) reported a other. Higher beta-blocker doses were associated with improved outcomes in chronic heart failure patients, regardless of atrial fibrillation status.